Elevated depressive symptoms among newer and younger healthcare workers in Japan during the COVID-19 pandemic.
COVID-19
Japan
SARS-COVID-2
clinical
depression
epidemiology of mental disorders
healthcare workers
Journal
Neuropsychopharmacology reports
ISSN: 2574-173X
Titre abrégé: Neuropsychopharmacol Rep
Pays: United States
ID NLM: 101719700
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
revised:
20
10
2021
received:
19
01
2021
accepted:
20
10
2021
pubmed:
4
11
2021
medline:
5
1
2022
entrez:
3
11
2021
Statut:
ppublish
Résumé
Depression is a frequent outcome of long-term stress, but no studies have examined depression rates among Japanese healthcare workers fighting the COVID-19 pandemic. Therefore, we conducted a web-based interview of hospital employees to assess depression prevalence and factors. This observational cohort study was conducted from July to August, 2020, as part of a mandatory health checkup of Juntendo University Hospital employees (Tokyo, Japan). A total of 4239 participants completed a web-based questionnaire on medical history and current health status. The Center for Epidemiologic Studies Depression Scale (CES-D) was used for self-assessment, with a score of ≥16 considered to indicate depression. Among all employees, the proportion of depression was 31.3% in 2020, the highest measured in the last 10 years and substantially greater than the pre-pandemic value in 2019 (27.5%). The proportion of depression for 2020 was significantly higher in new recruits than in employees with more than 2 years of experience (47.0% vs 29.9%, respectively, P < .0001) and in new recruits in 2019 (26.4%, P < .0001). When subdivided by occupation, nurses demonstrated the highest depression rate (43.2%), followed by paramedics (35.1%) and clerks (31.6%), whereas residents (22.9%), doctors (20.4%), teaching staff (18.0%), and part-time staff (15.3%) reported lower depression rates. The positive CES-D score significantly correlated with age (P < .0001). Younger and newer employees demonstrated the highest rates of depression independent of occupation. Therefore, mental healthcare programs focusing on these vulnerable groups need to be established.
Identifiants
pubmed: 34730870
doi: 10.1002/npr2.12217
pmc: PMC8646441
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
544-547Subventions
Organisme : Juntendo Institute of Mental Health
ID : 201701
Informations de copyright
© 2021 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.
Références
BMC Psychiatry. 2021 Jan 12;21(1):33
pubmed: 33435930
BMJ. 2020 May 5;369:m1815
pubmed: 32371465
Psychiatry Clin Neurosci. 2020 Sep;74(9):505-506
pubmed: 32609413
Neuropsychopharmacol Rep. 2021 Dec;41(4):544-547
pubmed: 34730870
Scand J Work Environ Health. 2020 Nov 1;46(6):639-644
pubmed: 32905601
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
Nat Hum Behav. 2021 Feb;5(2):229-238
pubmed: 33452498
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Eur Heart J Acute Cardiovasc Care. 2020 Apr;9(3):241-247
pubmed: 32342698
J Affect Disord. 2020 Oct 1;275:48-57
pubmed: 32658823